regeneron just built the first closed loop for drug discovery. think amex, but for life sciences

full stack 
- data
- relationships
- execution

target discovery to side effect mapping to repursing, all in one system. basically genetics is both signal and switch here. 

amex did it in fast, transactional domain where regeneron is doing it one of the slowest, messiest and highest stakes arenas we have.

FUD is not just defensible, its a multi decade margin in an $8T market with no real competition on the full loop...

summary

We have reached a sale agreement with @Regeneron, a leading US-based biotechnology company, to carry forward 23andMe’s mission and maintain customer privacy protections. Read more about today’s announcement here: https://t.co/0HeAPVmWzH

23andMe

regeneron just built the first closed loop for drug discovery. think amex, but for life sciences

full stack 
- data
- relationships
- execution

target discovery to side effect mapping to repursing, all in one system. basically genetics is both signal and switch here. 

amex did it in fast, transactional domain where regeneron is doing it one of the slowest, messiest and highest stakes arenas we have.

FUD is not just defensible, its a multi decade margin in an $8T market with no real competition on the full loop... 

https://x.com/23andMe/status/1924455650282639681